Table 4.
Allele frequencies in Hong Kong Chinese patients and controls*
| SNP | Control (n = 578) | SARS (n = 495) | OR (95% CI) | P |
| Number (%) | ||||
| Allele | ||||
| RANTES -403 | NS | |||
| A | 374 (32.4) | 331 (33.4) | ||
| G | 782 (67.7) | 659 (66.6) | ||
| RANTES -28 | <0.0001 | |||
| C | 1055 (91.3) | 786 (79.4) | ||
| G | 101 (8.7) | 204 (20.6) | 2.80 (2.11 – 3.71) | |
| RANTES ln1.1 | NS | |||
| C | 365 (31.6) | 325 (32.9) | ||
| T | 791 (68.4) | 665 (67.2) | ||
| IP-10 nt1811 | NS | |||
| A | 29 (2.5) | 40 (4.0) | ||
| G | 1127 (97.5) | 950 (96.0) | ||
| IP-10 nt2867 | NS | |||
| A | 31 (2.7) | 40 (4.0) | ||
| C | 1125 (97.3) | 950 (96.0) | ||
| Mig nt367 | NS | |||
| A | 34 (2.9) | 40 (4.1) | ||
| G | 1122 (97.1) | 938 (95.9) | ||
NS = not significant.
*P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex and age. After correction by Bonferroni method, the significant P value should be less than 0.007